Gehrmann et al. found MalaEx to significantly enhance IL-4 production in peripheral blood mononuclear cells (PBMCs) from AD patients, compared to those from healthy controls, in a dose-dependent manner [46]. This evidence concerns the gene IL4 and Alzheimer disease.